Senior Clinical Sciences Trial Leader (Multiple Openings)
Novartis
Summary
We are Clinical Sciences and Innovation at Novartis. A dynamic group of Clinical Trial Leaders (Clinical Scientists) who plan and execute early phase trials worldwide. From First-in-Human to ph2a studies and beyond. We design and operationalize trials, ensuring they run smoothly, on time and – most importantly – with patients’ interests to the fore.
Job description
As a member of our team, you will support or lead the clinical science and operations of planning and executing translational medicine clinical trials. Collaborate across our global network. Partner with outstanding physicians and scientists. Build therapeutic area expertise. Revolutionize next-generation, digital and patient-centric trial design.
Key Responsibilities
- Operationally and scientifically lead complex clinical studies
- Drive and deliver aspects of global clinical trial execution from study design, set-up and recruitment to final reporting
- Lead the matrix-management of robust global clinical trial teams, collaborating across the organization and externally with service providers/investigator sites
- Drive the development of clinical study protocols, clinical operations execution plans and other required documents
- Ensure quality conduct and document standards are applied across the clinical trial lifecycle
- Lead clinical data review
- Contribute to project/program level plans
- May mentor junior team members
- Support optimization of standard methodologies in clinical trial operations and adopt an open learning and sharing environment
- Unleash the value of data and digital within clinical studies
Essential Requirements
- Bachelors in life science/healthcare required; Advanced degree or equivalent education/degree in life sciences/ healthcare preferred (PhD/MD/ PharmD/ Masters)
- 6+ years’ experience in clinical trials development
- A broad knowledge of the drug development field; preferably within the pharma industry
- Strong project management experience; excellent planning, prioritization and organizational skills; used to managing multiple priorities concurrently
- Demonstrates high learning agility in therapeutic area
Desirable Requirements
- Experience in study design and protocol development/writing is highly desirable
Requirements
- Bachelors in life science/healthcare required
- Advanced degree or equivalent education/degree in life sciences/ healthcare preferred (PhD/MD/ PharmD/ Masters)
- 6+ years’ experience in clinical trials development
- A broad knowledge of the drug development field; preferably within the pharma industry
- Strong project management experience; excellent planning, prioritization and organizational skills; used to managing multiple priorities concurrently
- Demonstrates high learning agility in therapeutic area
- Experience in study design and protocol development/writing is highly desirable
Benefits
- Performance-Based Cash Incentive
- Annual Equity Awards
- Health Benefits
- Life Insurance
- Disability Benefits
- 401(k) With Company Contribution and Match
- Vacation
- Personal Days
- Holidays
- Other Leaves
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.